Mesenchymal stromal stem cell therapy in advanced interstitial lung disease - Anaphylaxis and short-term follow-up

Mesenchymal stromal stem cell therapy in advanced interstitial lung disease - Anaphylaxis and short-term follow-up

There are limited treatment options for advanced interstitial lung disease (ILD). We describe a patient of ILD treated with mesenchymal stromal stem cell infusion. The index patient had end-stage ILD due to a combination of insults including treatment with radiotherapy and a tyrosine kinase inhibito...

Full description

Bibliographic Details
Main Authors: Balamugesh Thangakunam, Devasahayam Jesudas Christopher, Vikram Mathews, Alok Srivastava
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Lung India
Subjects:
>Anaphylaxis
interstitial lung disease
stem cell therapy
Online Access:http://www.lungindia.com/article.asp?issn=0970-2113;year=2015;volume=32;issue=5;spage=486;epage=488;aulast=Thangakunam

Internet

http://www.lungindia.com/article.asp?issn=0970-2113;year=2015;volume=32;issue=5;spage=486;epage=488;aulast=Thangakunam

Similar Items